RD-0255359

N/A

Report date: 2024/07/05 13:43:01
NME

Base Information

Drug NameRD-0255359
Drug Alias NameRD-0255359
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionKRAS G12C degradersKRAS G12D degradersKRAS G12V degraders
TargetsKRAS G12CKRAS G12DKRAS G12V
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBetta Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBetta Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A